rGBM
Showing 1 - 25 of 34
Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)
Recruiting
- Glioma
- +7 more
- Laparoscopically harvested omental tissue autograft
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 31, 2023
Glioblastoma, Adult Trial in Cleveland (Pembrolizumab at 7 days prior, Pembrolizumab at 14 days post, Pembrolizumab at 35 days
Recruiting
- Glioblastoma, Adult
- Pembrolizumab at 7 days prior
- +3 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023
Recurrent Glioblastoma Trial (Niraparib, Re-irradiation (re-RT))
Not yet recruiting
- Recurrent Glioblastoma
- Niraparib
- Re-irradiation (re-RT)
- (no location specified)
Dec 23, 2022
Recurrent Glioblastoma Trial in United States (Carboplatin, Exablate BBBD)
Recruiting
- Recurrent Glioblastoma
- Carboplatin
- Exablate BBBD
-
Palo Alto, California
- +3 more
Nov 30, 2021
Recurrent Glioblastoma Trial in Worldwide (Exablate BBBD, Carboplatin)
Recruiting
- Recurrent Glioblastoma
- Exablate BBBD
- Carboplatin
-
Toronto, Ontario, Canada
- +3 more
Dec 6, 2021
Glioblastoma, Recurrent Glioblastoma Trial in Boston (Pembrolizumab, Olaparib, Temozolomide)
Not yet recruiting
- Glioblastoma
- Recurrent Glioblastoma
- Pembrolizumab
- +2 more
-
Boston, Massachusetts
- +2 more
Jul 14, 2022
Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme, Adult Trial in Phoenix (Pamiparib, Olaparib, Radiation therapy)
Recruiting
- Glioblastoma
- +2 more
- Pamiparib
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
May 3, 2022
Recurrent Glioblastoma Trial in Beijing (ASC40 tablets, Placebo tablets, Bevacizumab)
Recruiting
- Recurrent Glioblastoma
- ASC40 tablets
- +2 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital,Capital Medical University
Jun 28, 2022
Recurrent Glioblastoma, Glioblastoma - Category Trial in Edmonton (Repeat Surgical Management of Recurrent GBM)
Recruiting
- Recurrent Glioblastoma
- Glioblastoma - Category
- Repeat Surgical Management of Recurrent GBM
-
Edmonton, Alberta, CanadaUniversity of Alberta Division of Neurosurgery
Apr 5, 2022
Oncology Trial in Luxembourg (Personalized Functional Profiling)
Recruiting
- Oncology
- Personalized Functional Profiling
-
Luxembourg, Luxembourg
- +1 more
Feb 23, 2022
Recurrent Glioblastoma Trial in Taoyuan (NaviFUS System)
Recruiting
- Recurrent Glioblastoma
- NaviFUS System
-
Taoyuan, TaiwanChang Gung Medical Foundation
Sep 23, 2021
Recurrent Glioblastoma Trial in Tianjin (Niraparib)
Recruiting
- Recurrent Glioblastoma
-
Tianjin, Tianjin, ChinaTianjin Huanhu Hosptal
Jan 18, 2021
Glioblastoma, Recurrent Glioblastoma Trial in Iowa City (Static Magnetic and Electric (sBE) device, Lomustine, Bevacizumab)
Not yet recruiting
- Glioblastoma
- Recurrent Glioblastoma
- Static Magnetic and Electric (sBE) device
- +2 more
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Sep 20, 2022
Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity
Recruiting
- Astrocytoma, Grade IV
- +3 more
- CYNK-001 systemic and Intra cavity administration
-
Duarte, California
- +5 more
Jan 20, 2023
Recurrent Glioblastoma Trial in Beijing (Combined stereotactic radiosurgery and enhanced immunotherapy)
Recruiting
- Recurrent Glioblastoma
- Combined stereotactic radiosurgery and enhanced immunotherapy
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Nov 16, 2021
Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)
Recruiting
- Recurrent Glioblastoma Multiforme
- SNC-109 CAR-T Cells
-
Beijing, ChinaChinese PLA General Hospital
May 11, 2023
Malignant Glioma Trial in United States (PVSRIPO)
Active, not recruiting
- Malignant Glioma
- PVSRIPO
-
San Francisco, California
- +5 more
Jun 28, 2022
Glioblastoma Multiforme Trial in Baltimore (Dichloroacetate (DCA), Genotype)
Not yet recruiting
- Glioblastoma
-
Baltimore, MarylandJohns Hopkins University
Dec 10, 2021
Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma Trial in United States (lerapolturev, pembrolizumab)
Active, not recruiting
- Glioblastoma
- +3 more
- lerapolturev
- pembrolizumab
-
San Francisco, California
- +9 more
Nov 30, 2021
Glioblastoma Multiforme, Glioblastoma, Glioma Trial in Taoyuan City (NaviFUS System, Bevacizumab)
Recruiting
- Glioblastoma Multiforme
- +5 more
- NaviFUS System
- Bevacizumab
-
Taoyuan City, TaiwanLinkou Chang Gung Memorial Hospital
Aug 2, 2021